OINDPnews


Proveris Scientific

Products and Services

Strides and Orbicular partner on development of nasal sprays

Generics manufacturer Strides Pharma Science and CRO Orbicular Pharmaceutical Technologies, both based in India, have announced a new strategic partnership where Orbicular will formulate 4 nasal sprays to be manufactured and commercialized by Strides. According to the announcement, Strides will manufacture the nasal sprays at its facility in Chestnut Ridge, NY, USA … [Read more...] about Strides and Orbicular partner on development of nasal sprays

H&T Presspart and Hovione announce partnership for development of new DPI platform

Device developer and manufacturer H&T Presspart and particle engineering/spray drying specialist Hovione have announced an expansion of their existing relationship with an agreement for development of H&T Presspart's new Sunriser DPI technology. The two companies have previously partnered on development of the PowdAir Plus capsule-based dry powder inhaler. … [Read more...] about H&T Presspart and Hovione announce partnership for development of new DPI platform

GSK gives up exclusive license for use of Liquidia’s PRINT particle technology for inhaled formulations

Liquidia Corporation said that a new agreement will supersede its 2012 license agreement with GSK that gave GSK exclusive rights to develop certain inhaled formulations based on Liquidia's PRINT particle engineering technology. In 2015, GSK exercised an option giving it exclusive worldwide rights to develop PRINT formulations of inhaled therapies, with the exception … [Read more...] about GSK gives up exclusive license for use of Liquidia’s PRINT particle technology for inhaled formulations

Catalent to manufacture HRT’s RiVive naloxone nasal spray

Catalent and Harm Reduction Therapeutics (HRT) announced that they have signed a commercial supply agreement for the manufacture of HRT's RiVive intranasal naloxone. The news comes shortly after HRT said that it would receive an additional $9 million in funding from Purdue Pharma that would be used to prepare for possible commercialization of RiVive. The FDA … [Read more...] about Catalent to manufacture HRT’s RiVive naloxone nasal spray

Stevanato Group to supply syringes for Recipharm’s Resyca syringe-based SMIs

The Stevanato Group has announced that it will manufacture pre-fillable glass syringes for Recipharm's Resyca pre-filled syringe soft mist inhalers for the delivery of biologics. According to Stevanato Group, the interior of the Alba glass syringe has a silicone oil-based coating for improved particle release. The Resyca SMI is the product of a 2020 joint … [Read more...] about Stevanato Group to supply syringes for Recipharm’s Resyca syringe-based SMIs

Lonza Small Molecules adds powder characterization capabilities at Florida facility

The Lonza Small Molecules facility in Tampa, FL, USA has upgraded its powder analysis capabilities, the company said. In May 2022, Lonza announced that it was expanding its dry powder testing facilities in Tampa in order to increase its DPI development capacity. According to Lonza, the Tampa site recently added a Freeman Technologies FT4 universal powder flow … [Read more...] about Lonza Small Molecules adds powder characterization capabilities at Florida facility

Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products

Aptar Pharma announced that it has launched a metal-free multidose nasal spray pump called APF Futurity for delivery of over-the-counter formulations. According to Aptar Pharma, APF Futurity is designed to be recyclable without removing the pump from a container bottle and has received Class AA certification from cyclos-HT. Aptar Product Sustainability Director … [Read more...] about Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products